“…The effectiveness of transdermal drug delivery depends on the drug's ability to reach therapeutic levels by penetrating the skin sufficiently (Müller et al, 2002). For transdermal drug delivery, nanostructured lipid carriers (NLC) are an attractive strategy since the adhesion of an NLC to the skin surface provides an occlusive effect, which can eventually lead to an increase in skin hydration and promote the deposition of drugs by reducing corneocyte packing and widening inter-corneocyte 5 gaps (Schäfer-Korting et al, 2007;Guo et al, 2012). Furthermore, the lipid and surfactant components can enhance permeation by reducing the barrier properties of the stratum corneum, thereby increasing drug permeation through the skin (Joshi and Patravale, 2006).…”